Skip to content

13F-HR filed by Atle Fund Management AB

Atle Fund Management AB filed this 13F-HR for the quarter ended 2026-03-31, filed 2026-05-11, with 39 holding rows worth $309,685,250.

Accession
0001381843-26-000004
Filed
2026-05-11
Accepted by EDGAR
acceptance time not in the bulk data set
Ingested
Source
SEC quarterly data set

Original filing

13F report for Q1 2026

A holdings report, 39 entries on the cover page, a total value of $309,685,250 stated on the cover page (in dollars after the unit check, H1), rows summing to $309,685,250 with VALUE read as dollars as filed, 13F file number 028-12171. The quarter's positions are built on this report. The resolved quarter.

The information table after summing rows of one CUSIP and put or call (H4), with the CUSIP and issuer name as filed. Values in dollars after the unit check (method).

Issuer as filedCUSIPClassAmountValueValue read asType
Eli Lilly and Company532457108COM39,722$26,845,326dollars as filed
Merck & Co.,Inc.58933Y105COM33,853$22,917,169dollars as filed
Thermo Fisher Scientific Inc.883556102COM22,986$14,449,998dollars as filed
BEONE MEDICINES LTD SPONSORED ADS07725L102ADR41,717$12,137,163dollars as filed
Johnson & Johnson478160104COM92,377$11,943,093dollars as filed
BRIDGEBIO PHARMA INC10806X102COM111,363$11,893,481dollars as filed
Vertex Pharmaceuticals Incorporated92532F100COM22,984$11,167,965dollars as filed
AbbVie,Inc.00287Y109COM108,181$10,385,799dollars as filed
Stryker Corporation863667101COM26,835$9,579,712dollars as filed
Intuitive Surgical,Inc.46120E602COM70,851$9,444,763dollars as filed
IONIS PHARMACEUTICALS INC COM462222100Stock27,873$9,398,790dollars as filed
MIRUM PHARMACEUTICALS INC604749101COM195,768$9,397,540dollars as filed
CVS Health Corporation126650100COM23,773$9,267,221dollars as filed
REVOLUTION MEDICINES INC COM76155X100Stock617,245$9,077,023dollars as filed
Boston Scientific Corporation101137107COM40,432$8,844,236dollars as filed
Amgen Inc.031162100COM21,903$8,716,028dollars as filed
EDWARDS LIFESCIENCES CORP COM28176E108Stock106,518$8,266,658dollars as filed
ALKERMES PLCG01767105SHS242,473$8,235,520dollars as filed
INCYTE CORP COM45337C102Stock50,796$7,974,128dollars as filed
NEUROCRINE BIOSCIENCES INC64125C109COM89,685$7,854,470dollars as filed
Gilead Sciences,Inc.375558103COM47,967$7,156,510dollars as filed
KRYSTAL BIOTECH INC COM501147102Stock37,579$6,793,816dollars as filed
CENCORA INC COM03073E105Stock23,470$6,603,222dollars as filed
IRHYTHM HOLDINGS INC COM450056106Stock22,322$6,259,662dollars as filed
INSMED INC COM PAR $.01457669307Stock97,438$5,955,071dollars as filed
NEWAMSTERDAM PHARMA CO NVN62509109COMMON STOCK94,796$5,508,280dollars as filed
CELCUITY INC15102K100COM141,296$5,141,208dollars as filed
ABIVAX SA-00370M103SPONSORED ADS31,590$4,783,596dollars as filed
CARDINAL HEALTH INC14149Y108COM108,682$4,768,210dollars as filed
IDEAYA BIOSCIENCES INC COM45166A102Stock31,133$4,011,494dollars as filed
TANGO THERAPEUTICS INC87583X109COM29,915$3,629,578dollars as filed
SPYRE THERAPEUTICS INC00773J202COM NEW62,735$3,485,807dollars as filed
DISC MEDICINE INC COM254604101Stock107,255$3,188,687dollars as filed
COMPASS THERAPEUTICS INC20454B104COM41,831$3,051,055dollars as filed
UnitedHealth Group Inc91324P102COM14,636$2,772,424dollars as filed
DEXCOM INC COM252131107Stock584,332$2,639,923dollars as filed
BICARA THERAPEUTICS INC055477103COM1,169,634$2,315,235dollars as filed
SOLENO THERAPEUTICS INC834203309COM90,184$2,207,336dollars as filed
PYXIS ONCOLOGY INC COMMON STOCK747324101Stock197,036$1,618,053dollars as filed

Amendment chain

FilingRoleFiledAcceptedIngested
13F-HR 0001381843-26-000004this filing2026-05-11acceptance time not in the bulk data set